World's Best Scientists 2026 revealed!
Mitsuomi Hirashima

Mitsuomi Hirashima

D-Index & Metrics

Immunology

D-Index
69
Citations
19068
World Ranking
2495
National Ranking
97

Mitsuomi Hirashima publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Mitsuomi Hirashima sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 246 publications — 50th percentile

50% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Mitsuomi Hirashima D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Mitsuomi Hirashima sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 69 D-Index — 50th percentile

50% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Mitsuomi Hirashima is affiliated with Kagawa University in Japan and specializes in research that spans immunology, microbiology, biochemistry, genetics, and molecular biology. Their work primarily addresses molecular mechanisms involved in cancer biology and immune system function, with a particular focus on the roles of galectins and signaling pathways in disease.

Their main research topics include:

  • Galectins and Cancer Biology
  • Signaling Pathways in Disease
  • Peptidase Inhibition and Analysis
  • Circular RNAs in diseases
  • Glycosylation and Glycoproteins Research
  • Protein Tyrosine Phosphatases
  • T-cell and Retrovirus Studies

The scientist has contributed to multiple publications examining the biological functions of galectin-9 and its effects on tumor growth and immune cell behavior. Recent papers authored or co-authored by Hirashima include:

  • "Galectin-9 mediates neutrophil capture and adhesion in a CD44 and β2 integrin-dependent manner," 2021, The FASEB Journal
  • "Galectin-9 suppresses the tumor growth of colon cancer in vitro and in vivo," 2021, Oncology Reports
  • "Antitumor Effect of Galectin-9 on Cell Proliferation and Tumor Growth of Human Duodenal Adenocarcinoma Cells," 2023, Anticancer Research
  • "Editor's Note: Targeting Activating Transcription Factor 3 by Galectin-9 Induces Apoptosis and Overcomes Various Types of Treatment Resistance in Chronic Myelogenous Leukemia," 2024, Molecular Cancer Research

The venues where Hirashima frequently publishes include The FASEB Journal, Oncology Reports, Anticancer Research, and Molecular Cancer Research. Their collaborative work involves several frequent co-authors, such as Toshiro Niki, Kei Takuma, Kyoko Oura, Taiga Chiyo, and Asif Iqbal.

The research contributions of Mitsuomi Hirashima reflect an interdisciplinary approach combining immunology and molecular biology to study cancer progression and immune modulation. Their focus on galectin proteins ties into broader investigations of signaling pathways and cellular interactions in disease contexts.

Best Publications

  • Tumor-infiltrating DCs suppress nucleic acid–mediated innate immune responses through interactions between the receptor TIM-3 and the alarmin HMGB1

    Shigeki Chiba;Muhammad Baghdadi;Hisaya Akiba;Hironori Yoshiyama

  • Promotion of tissue inflammation by the immune receptor Tim-3 expressed on innate immune cells.

    Ana C. Anderson;David E. Anderson;Lisa Bregoli;William D. Hastings

  • Coexpression of Tim-3 and PD-1 identifies a CD8+ T-cell exhaustion phenotype in mice with disseminated acute myelogenous leukemia

    Qing Zhou;Meghan E. Munger;Rachelle G. Veenstra;Brenda J. Weigel

  • Human Galectin-3 Is a Novel Chemoattractant for Monocytes and Macrophages

    Hideki Sano;Daniel K. Hsu;Lan Yu;John R. Apgar

  • Galectin-9 suppresses the generation of Th17, promotes the induction of regulatory T cells, and regulates experimental autoimmune arthritis

    Masako Seki;Souichi Oomizu;Ken mei Sakata;Atsuko Sakata

  • Blood diffusion and Th1-suppressive effects of galectin-9-containing exosomes released by Epstein-Barr virus-infected nasopharyngeal carcinoma cells.

    Jihène Klibi;Toshiro Niki;Alexander Riedel;Catherine Pioche-Durieu

  • Galectin-9 Induces Apoptosis Through the Calcium-Calpain-Caspase-1 Pathway

    Yumiko Kashio;Kazuhiro Nakamura;Mohammad J. Abedin;Masako Seki

  • Tim-3 is an inducible human natural killer cell receptor that enhances interferon gamma production in response to galectin-9

    Michelle K. Gleason;Todd R. Lenvik;Valarie McCullar;Martin Felices

  • IL-12 upregulates TIM-3 expression and induces T cell exhaustion in patients with follicular B cell non-Hodgkin lymphoma

    Zhi Zhang Yang;Deanna M. Grote;Steven C. Ziesmer;Toshiro Niki

  • Human ecalectin, a variant of human galectin-9, is a novel eosinophil chemoattractant produced by T lymphocytes

    Ryoji Matsumoto;Hiroyuki Matsumoto;Masako Seki;Mitsumi Hata

  • Galectin-9-CD44 Interaction Enhances Stability and Function of Adaptive Regulatory T Cells

    Chuan Wu;Theresa Thalhamer;Rafael F. Franca;Sheng Xiao

  • Tim-3/Galectin-9 Pathway: Regulation of Th1 Immunity through Promotion of CD11b+Ly-6G+ Myeloid Cells

    Valerie Dardalhon;Ana C. Anderson;Jozsef Karman;Lionel Apetoh

  • An Emerging Role for Galectins in Tuning the Immune Response: Lessons from Experimental Models of Inflammatory Disease, Autoimmunity and Cancer

    Gabriel Adrián Rabinovich;F. T. Liu;M. Hirashima;A. Anderson

  • Exosomes released by EBV-infected nasopharyngeal carcinoma cells convey the viral Latent Membrane Protein 1 and the immunomodulatory protein galectin 9

    Cécile Keryer-Bibens;Catherine Pioche-Durieu;Cécile Villemant;Sylvie Souquère

  • Galectin-9 Increases Tim-3+ Dendritic Cells and CD8+ T Cells and Enhances Antitumor Immunity via Galectin-9-Tim-3 Interactions

    Keiko Nagahara;Tomohiro Arikawa;Souichi Oomizu;Keiichi Kontani

  • Galectin-9 induces maturation of human monocyte-derived dendritic cells.

    Shu-Yan Dai;Ryusuke Nakagawa;Aiko Itoh;Hiromoto Murakami

  • Galectin-9 as a prognostic factor with antimetastatic potential in breast cancer.

    Akemi Irie;Akira Yamauchi;Keiichi Kontani;Minoru Kihara

  • Interferon-γ stimulates the expression of galectin-9 in cultured human endothelial cells

    Tadaatsu Imaizumi;Mika Kumagai;Naoko Sasaki;Hidekachi Kurotaki

  • A Crucial Role for Kupffer Cell-Derived Galectin-9 in Regulation of T Cell Immunity in Hepatitis C Infection

    John A. Mengshol;Lucy Golden-Mason;Tomohiro Arikawa;Maxwell Smith

  • Galectin-9 is a high affinity IgE-binding lectin with anti-allergic effect by blocking IgE-antigen complex formation

    Toshiro Niki;Shoko Tsutsui;Shigeru Hirose;Sachiko Aradono

  • Possible role of galectin-9 in cell aggregation and apoptosis of human melanoma cell lines and its clinical significance.

    Toshiro Kageshita;Yumiko Kashio;Akira Yamauchi;Masako Seki

Frequent Co-Authors

Akira Yamauchi
Akira Yamauchi Kawasaki Medical School
Akira Yamauchi
Akira Yamauchi Nagoya University
Masayuki Ando
Masayuki Ando Kumamoto University
Vijay K. Kuchroo
Vijay K. Kuchroo Harvard University
Tadaatsu Imaizumi
Tadaatsu Imaizumi Hirosaki University
Hugo R. Rosen
Hugo R. Rosen University of Southern California
Kei Satoh
Kei Satoh Hirosaki University
Ana C. Anderson
Ana C. Anderson Brigham and Women's Hospital
Barry T. Rouse
Barry T. Rouse University of Tennessee at Knoxville
Michael Croft
Michael Croft La Jolla Institute For Allergy & Immunology

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, related fields such as nursing and healthcare offer various online degree options that can complement your expertise. Nursing professional programs, including some of the cheapest psych NP programs online, provide affordable pathways to specialize in psychiatric care. This intersection of immunology and mental health is gaining prominence as the immune system’s role in psychiatric conditions becomes better understood.

Career-wise, understanding potential earnings is crucial. Many advanced practice nurses, especially those with a Doctor of Nursing Practice (DNP), explore how much they can earn across different regions. The resource on how much do DNPs make offers valuable insights into salary expectations, helping graduates make informed decisions about where to work and specialize.

Nurses aiming to refine their skills can consider transitions such as moving from a Family Nurse Practitioner to an Acute Care NP. Guidance on FNP to acute care NP career shifts helps immunology professionals broaden their clinical expertise in critical care settings, which often demand strong immunological knowledge.

Lastly, accelerated options enable faster entry into advanced nursing roles. The list of accelerated NP programs online serves as a great starting point for those eager to expand their immunology-related careers efficiently.

Best Scientists Citing Mitsuomi Hirashima

Trending Scientists

Recently Published Articles